Recursion Pharmaceuticals, Inc. (BMV:RXRX)
Mexico · Delayed Price · Currency is MXN 86.00
-3.00 (-3.37%)
At close: Dec 5, 2025
Recursion Pharmaceuticals Revenue
Recursion Pharmaceuticals had revenue of $5.18M USD in the quarter ending September 30, 2025, a decrease of -80.16%. This brings the company's revenue in the last twelve months to $43.69M, down -32.98% year-over-year. In the year 2024, Recursion Pharmaceuticals had annual revenue of $58.84M with 32.00% growth.
Revenue (ttm)
$43.69M
Revenue Growth
-32.98%
P/S Ratio
55.74
Revenue / Employee
$54.61K
Employees
800
Market Cap
44.67B MXN
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 58.84M | 14.26M | 32.00% |
| Dec 31, 2023 | 44.58M | 4.73M | 11.88% |
| Dec 31, 2022 | 39.84M | 29.67M | 291.46% |
| Dec 31, 2021 | 10.18M | 6.22M | 156.89% |
| Dec 31, 2020 | 3.96M | 1.64M | 70.85% |
| Dec 31, 2019 | 2.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wal-Mart de México | 1.00T |
| Arca Continental | 250.90B |
| Industrias Peñoles | 142.01B |
| Grupo Financiero Banorte | 134.72B |
| Grupo Elektra | 114.48B |
| Quálitas Controladora | 72.66B |
| GMéxico Transportes | 64.06B |
| Becle | 44.91B |